Technimark Acquires Rage Plastics, Bolstering Healthcare Manufacturing

ASHEBORO, N.C. – March 16, 2026 – Global manufacturing giant Technimark has acquired Rage Custom Plastics, a family-owned specialist in medical and consumer healthcare plastics, in a strategic move that significantly deepens its commitment to the burgeoning healthcare sector. The acquisition expands Technimark's U.S. footprint into the Mid-West and Mid-Atlantic and adds crucial blow molding capabilities to its advanced manufacturing portfolio.

Announced today, the deal brings Rage Custom Plastics, with its 65-year history and facilities in Ohio and Virginia, under the umbrella of the Asheboro-based Technimark. This move is the latest in a series of calculated expansions by Technimark, underscoring a clear strategy to dominate the highly specialized field of medical component manufacturing.

A Calculated Play in a High-Growth Arena

The acquisition is not an isolated event but a key part of a deliberate, multi-year growth strategy heavily influenced by Technimark's private equity ownership. Backed by Oak Hill Capital and Pritzker Private Capital, Technimark has been on an aggressive expansion path focused squarely on the healthcare market. This has included acquiring Ireland's Tool & Plastic Industries in 2020, investing $62 million to expand its Asheboro healthcare production in 2022, and committing €26 million to double its Irish facility's size that same year.

This intense focus is well-placed. The global medical plastics market is projected to grow from approximately $26.8 billion in 2024 to over $44.6 billion by 2032, driven by an aging global population, the increasing prevalence of single-use medical devices for infection control, and the rising demand for sophisticated, minimally invasive surgical tools. Technimark's acquisition of Rage is a direct response to this demand, positioning the company to capture a larger share of this lucrative market.

"Rage's talented team, strong culture, and long-term partnerships with strategic healthcare customers make them a perfect acquisition for us," said Kris Peavy, Technimark's Chief Commercial Officer and President of Healthcare. "We are excited to welcome the Rage team to the Technimark global organization and look forward to building a stronger future together as we continue advancing our mission to make what makes life better."

From Family Legacy to Global Scale

For Rage Custom Plastics, the acquisition marks a new chapter in a 65-year story. Founded as a family business, Rage built a sterling reputation for quality and innovation from its headquarters in Hilliard, Ohio, and its operations in Lewis Center, Ohio, and Hurt and Altavista, Virginia. The transition from a family-run operation to part of a global corporation was framed by its leadership as a natural evolution built on shared principles.

Dan Saliaris, Rage's Chief Executive Officer, highlighted the cultural synergy between the two companies. "My father started Rage 65 years ago with a simple belief: Take care of your people, do right by your customers, and the business will take care of itself," Saliaris stated. "Technimark's values, culture, and long-term vision mirror our own, and they bring capabilities and global scale that will create tremendous opportunity for our employees and customers. I feel incredibly proud of what we've built — and confident that Rage's legacy will be even stronger as part of Technimark."

This expansion into the Mid-West and Mid-Atlantic provides Technimark with a strategic geographic advantage, bringing production closer to key customer hubs and tapping into established manufacturing workforces. While the immediate economic impact on the communities of Hilliard, Lewis Center, Hurt, and Altavista is yet to be detailed, Technimark's history suggests a positive outlook. Previous expansions, such as the one in Asheboro that created 220 jobs, demonstrate a pattern of investment and job creation, suggesting that integrating Rage's facilities could bring new stability and growth to these regional manufacturing centers.

The Competitive Edge of Specialized Capabilities

Beyond geographic expansion, the acquisition significantly enhances Technimark’s technical arsenal by integrating Rage’s expertise in blow molding. While Technimark is a leader in precision injection molding—a process used to create solid, intricate plastic parts—blow molding is essential for producing hollow, thin-walled components. This capability is critical in the medical field for products like IV bags, specimen collection containers, medical balloons, and protective cases for sensitive equipment.

Injection blow molding, a specialty of Rage, offers superior dimensional accuracy, uniform wall thickness, and smooth, particle-free interior surfaces—all non-negotiable requirements for medical applications where sterility and precision are paramount. By adding this expertise, Technimark can now offer its healthcare clients a more comprehensive, end-to-end manufacturing solution. This move allows the company to vertically integrate more of the production process for complex medical devices, reducing reliance on multiple suppliers and strengthening supply chain resilience for its customers.

The ability to offer both advanced injection and blow molding under one corporate roof positions Technimark as a more versatile and powerful partner for medical device companies. As the healthcare industry continues to demand more complex, cost-effective, and reliable components, this combined expertise will be a crucial differentiator, enabling the development of innovative products that meet the rigorous standards of modern medicine.